Benzinga | Feb 25, 2021 06:54AM EST

Madrigal Pharmaceuticals Q4 EPS $(3.82) Down From $(1.80) YoY

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(3.82) per share. This is a 112.22 percent decrease over losses of $(1.80) per share from the same period last year.